About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of this group is to develop translational and clinical research in rehabilitation. From the lab-based cellular level of understanding injury to rehabilitation and recovery, our researchers are dedicated to the development and translation of more effective strategies to promote prevention, functional recovery, and improved quality of life after disability.
Our vision: make disability preventable, liveable and curable.
Our mission: conduct research and training towards the development and translation of more effective strategies to promote prevention, functional recovery, and improved quality of life after disability.
Principal investigators, investigators and associate members come together from many different departments at the Rehabilitation Service and reflecting the wide breadth of expertise through the disability. The principal investigators and researchers include professors in Universitat Autònoma and Universitat Blanquerna.
Special objectives in innovation areas with in collaboration with pharmaceutical companies (pluripotencial cells, botulinum toxins), other biotechnology companies (diagnosis, prevention and management), participating in technology transference projects with other research groups, and involvement in projects and networks endorsed by European Scientific Societies.
The Research Group of Physical Medicine and Rehabilitation collaborates with the University of Andorra (UdA), specifically with Mercè Avellanet's team; and with the Universitat Jaume I of Valencia (UJI), team of Carlos Suso.
IP: Mar Melendez Plumed
IP: Judith Sánchez Raya
IP: Rehabilitació Sol Pelvià
IP: Lluisa Montesinos Magraner
IP: Jordi Barquinero Mañez Collaborators: Francina Munell Casadesus, Esther Toro Tamargo Funding agency: Instituto de Salud Carlos III Funding: 139150 Reference: PI19/00295 Duration: 01/01/2020 - 30/06/2024
IP: Susana Rodriguez Gonzalez Collaborators: - Funding agency: AAL International Association Funding: 138162.64 Reference: AAL/2020/RODRIGUEZ_NEST Duration: 01/07/2021 - 31/01/2024
IP: - Collaborators: Oscar Persiva Morenza, Judith Sacanell Lacasa, Aroa Gomez Brey, Alba Gómez Garrido, Cristopher Alan Mazo Torre, Gonzalo Ballesteros Reviriego, Bernat Planas Pascual, Teresa Pont Castellana Funding agency: Instituto de Salud Carlos III Funding: 94380 Reference: PI21/01911 Duration: 01/01/2022 - 21/06/2023
IP: - Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez Funding agency: Instituto de Salud Carlos III Funding: 45375 Reference: PI21/00448 Duration: 01/01/2022 - 30/06/2026
MouthX, developed by the company Aurax, allows people with reduced mobility in the upper extremities to have access to essential digital tools for communication, work and leisure, with the aim of improving their independence and emotional well-being.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
En la mateixa trobada la SEP va decidir atorgar per primera vegada una beca per fer formació a l'estranger de dos mesos. La beca es va atorgar a la Dra. Teresa Crespo, adjunta a la Unitat de Lesionats Medul·lars de Vall d’Hebron.
